Ophthalmic Sciences announced the release of IOPerfect, a first-of-its-kind AI-based contactless IOP measuring device. The unit combines AI-generated visual analysis in a virtual reality-like headset, offering telediagnosis and remote glaucoma monitoring, the company stated in a news release.

Through the VR-like headset, patients can check their IOP at home in about 2 minutes, without the need for eye drops or continual calibration. The test is unaffected by corneal thickness due to a proprietary algorithm used to analyze the image for vascular pressure response.

“We are excited to have our technology serve as a meaningful tool to help fight the glaucoma epidemic and prevent millions from going blind,” Ophthalmic Sciences CEO Ariel Weinstein said in a news release. “Growing exposure to phone and computer screens appears to be linked to increased glaucoma prevalence. Along with an aging population, the risk keeps getting higher, increasing the need for early diagnosis. But most importantly, the past year has proven the value of telediagnosis, and this fact has attracted significant attention from clinicians and investors in our venture.”

The IOPerfect device applies mild, controlled air pressure within its headset, while video cameras display the differences in pressure response of internal vs external eye blood vessels, the manufacturer said. The captured data are then uploaded to a secure cloud for analysis and clinical interpretation.

IOPerfect is currently undergoing regulatory review and will be available in the United States and Europe in 2023, according to the company. In the future, the company plans to release a suite of remote eyecare diagnostic devices based on the IOPerfect technology, for the early detection of cataract, corneal edema, and exophthalmia, as well as central/branch vascular occlusions and ocular motor disorders.